Bob Miglani worked at Pfizer Inc. in roles of increasing responsibility over the course of 23 years, spanning many functions including sales, marketing research, pricing and reimbursement, communications, patient advocacy, market access, partnership development, strategy and external medical affairs. Bob’s leadership helped Pfizer develop strong partnerships with organizations such as the World Medical Association and AARP. In addition, Bob served as Chief of Business Development for a disruptive startup, Applied DNA Sciences, where he helped bring in a large strategic partner to help grow the company’s business in life sciences. As a thought leader, Bob speaks to organizations globally on new and exciting technologies in healthcare, global change and embracing disruption.
Prof. Joseph M. Chalil, MD, MBA, FACHE, is an expert in Pharmaceutical and Biotechnology Clinical Development and Medical Affairs with over 17 years’ experience in the field. Dr. Chalil is a member of Healthcare Advisory Board and an Adjunct Professor at Nova Southeastern University in Florida. He is the current Chairman of the Global Clinical Trial Network of American Association of Physicians of Indian Origin (AAPI), the second largest physician organization in the U.S., second only to AMA.
Formerly, a Physician Executive at Boehringer Ingelheim and a veteran of the U.S. Navy Medical Corps, Dr. Chalil is also board certified in healthcare management, and has been awarded Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems and other healthcare organizations.